Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Emergent BioSolutions USD 693.2M 522.5M 2023-06
Exact Sciences USD 514.7M 38.19M 2023-12
Exelixis USD 376.82M 37.2M 2023-09
Heron Therapeutics USD 79.74M 6.98M 2023-09
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Ironwood Pharmaceuticals USD 276.1M 4.48M 2023-12
Lonza CHF 2.71B 369M 2023-06
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Myriad Genetics USD 155.9M 53.4M 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12
Vanda Pharmaceuticals USD 87.4M 6.4M 2023-06
Xoma USD 10.33M 3.25M 2023-09



Emergent BioSolutions Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.